Montelukast Prescribing at WIGHT PRIMARY PARTNERSHIPS LTD
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,744
Total Quantity
54.4K
NHS Cost
£2.7K
vs National Avg
+154.7%
WIGHT PRIMARY PARTNERSHIPS LTD prescribed 1,744 items of Montelukast over the last 12 months at a cost of £2,674 to the NHS. This is 154.7% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
161
Jul 2026
129
Jul 2026
145
Jul 2026
149
Jul 2026
142
Jul 2026
151
Jul 2026
143
Jul 2026
157
Jul 2026
144
Jul 2026
141
Jul 2026
133
Jul 2026
149
Prescribing Details
| Total Items | 1,744 |
|---|---|
| Total Quantity | 54,413 |
| Total NHS Cost | £2,674 |
| Presentations | 5 different forms |
| vs National Average | +154.7% |
Montelukast Prescribing Comparison
| This practice | 1,744 items |
|---|---|
| National average per practice | 685 items |
| Difference | +154.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.